Following exposure to aerosols of depleted uranium (DU), biological samples show the presence of a synthetic mixture of natural uranium and DU. By partitioning the uranium in the 24-h urine sample along the isotopic fractions of natural uranium and DU, one can study the kinetics of these subpopulations independently. A linear model is developed to estimate the lung burden of DU from measurements of DU in 24-h urine samples, years after inhalational exposure to aerosols of DU. This model takes into account the intracellular dissolution of the retained particles and the precipitation of a significant fraction of the dissolved DU as insoluble uranyl phosphates.
INTRODUCTION
Depleted uranium (DU) is a waste product of the enrichment process, with commercial and military uses. The isotopic fractions of DU and natural uranium can be found elsewhere in the literature.
Different studies (1, 2) indicate that the firing of armour-piercing penetrators containing DU results in the release of aerosolised ceramic oxides into the atmosphere. The particles created are of such dimensions that can reach and deposit on the alveolar surface (3, 4) . Studies published by Horan et al. (5) and Duraković et al. (6) show that 8-9 y after being exposed to aerosols of DU, veterans of the Persian Gulf War I were excreting measurable amounts of DU in 24-h urine samples. In a study by Parrish et al. (7) the authors report that approximately 20 y after cessation of primary inhalational exposure to aerosols of DU, affected individuals were still showing measurable amounts of DU in 24-h urine samples. These results indicate that (i) inhaled DU has been internalised, and (ii) the internalised uranium can be partitioned into two sectors along the isotopic fractions of DU and natural uranium, which makes possible the study of the time evolution of the amount of DU internalised.
Lung clearance mechanisms
Retention or lung burden is the amount of inhaled particles in the lungs and it is equal to the deposition minus the clearance, which is done by (i) mechanical clearance and (ii) particle dissolution. The rate of mechanical clearance of particulate matter is species dependent, but independent of the material (8) .
The mechanical clearance of the upper airways is predominantly done by migration to the mucociliary escalator toward the pharynx and it is essentially completed in about 1-2 d (9 -12) . The mechanical clearance of the alveolar region is mainly done by alveolar macrophages (AM) phagocytosis with transport of sequestered particles, predominantly to the mucociliary escalator (13 -15) . The process of phagocytosis commences within minutes to few hours after the deposition of particles in the alveolar region, with half-times of 0.6 -7 h (16) , and for as long as the lung burden does not overwhelm the phagocytic capacity of the AM, the process will essentially be completed within 1 d (17, 18) . In humans, the clearance of the alveolar region may take months to years (19) . There is always translocation of the deposited particles to the regional lymph nodes, which may involve any or all of the following: (i) endocytosis of the insoluble free particles by Type I cells, (ii) free particles translocation to the interstitium and (iii) migration of particle-laden AM to the interstitium. Once in the interstitium, free particles can be readily phagocytised by the interstitial macrophages (14, 20, 21) and can remain sequestered or slowly migrate to the lymph nodes with half-times that can vary from a few months to years (22 -25) . Based on the available data, it has been concluded that dogs provide a more useful model for predicting the retention of sequestered particles in the lymph nodes of humans (26, 27) . In their comparative study of the retention of particles inhaled by dogs, rats and mice, Snipes et al. (28) suggest an AM-mediated alveolar clearance rate to the lymph nodes of 0.0002 d
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High lung burden occurs when the deposition rate exceeds the clearance rate and in rats this results in (i) a decrease in AM motility and (ii) an accumulation of particles on the surface of the alveoli (29) .
*Corresponding author: mjvv@magma.ca Such phenomenon has not been observed in humans. A study (30) on the retention and clearance of respirable coal dust by the lungs and lymphatic nodes in retired coal miners indicates that there is a significant translocation to the interstitium where insoluble particles become essentially sequestered with a very low rate of clearance to the lymph nodes, with no retardation of the migratory function of overloaded AM or with a much less than expected retardation of the migratory function from studies with rats. In this study the authors suggest an AM-mediated alveolar clearance rate to the mucociliary escalator of 0.001 d 21 . Studies on the solubility of uranium oxides indicate that uranium oxides that are poorly soluble in water (31) , are soluble in biological fluids (32 -34) , and dissolve at different rates in extracellular and intracellular fluids (35 -37) . Macrophages ingest and transport insoluble particles of every type and are able to dissolve particles within the acidic phagolysosomes.
INHALATIONAL EXPOSURE
As indicated, the firing of armour piercing DU penetrators results in the release of aerosolised ceramic oxides into the atmosphere. According to a study by Mitchel and Sunder (38) , a DU particle is composed of 47% U 3 O 7 , 44% U 3 O 8 and 9% UO 2 , while Chazel et al. (39) found the DU particle to be composed of 30-40% U 3 O 8 , 25 -40% U 4 O 9 and 20% UO 3 . Glissmeyer et al. (40) reported a DU particle composition of 75% U 3 O 8 and 25% UO 2 , while in a later study (41) the reported fractions are 80-95% uranium oxides, with 75% U 3 O 8 , plus 4-19% iron oxide with minor amounts of other elements.
The data on DU aerosol reported in the Capstone Report (2) suggests that the DU aerosol is on average 92% U 3 O 8 , 5% UO 3 and 3% U 4 O 9 . The report also indicates that the X-ray diffractometry analysis of the DU samples showed an overlap on the major peaks corresponding to U 3 O 8 and UO 3 , thus not allowing a clear separation between the two patterns. Therefore, the 92% of U 3 O 8 actually includes an unspecified small amount of UO 3 . The analysis also indicated the presence of small amounts of
The oxidation sequence of uranium at high temperature and no water or low water vapour is: (42, 43) . Due to the very high temperatures developed during the explosion, as well as from weathering, the DU particle is mostly uranium oxides in different states of oxidation, which together with likely differences in the physical characteristics of the DU particles result in such an array of diverse experimental results.
As mentioned, the process of phagocytosis is essentially completed within 1 d. Since a relatively small number of deposited particles escapes phagocytosis (14) , one could expect that the absorbed DU is not the result of the extracellular dissolution of the DU particles. The internalisation of the DU cannot be a consequence of a collapse of the migratory function, as such a phenomenon has not been observed in humans. It can, however, be attributed to the fact that because phagocytised DU particles dissolve inside the phagolysosomal vacuoles, some of the dissolved DU will enter the systemic circulation as the AM makes its way out the alveolar region towards the mucociliary escalator.
Uranium oxides in the body are metabolised, mainly, to the uranyl ion UO 2 2þ (44) . Thus, most metabolised DU resulting from inhalational exposure detected in a urine sample will be in the form of a uranyl compound; there is no residual knowledge of the physical and chemical composition of the DU particle.
Intracellular dissolution of uranium oxides
In their study on the in vitro dissolution of UO 3 by Sprague -Dawley rat AM in alginate beads, Ansoborlo et al. (45) found dissolution half-times of 10.8 and 5.5 d, for particles phagocytised by the AM and particles immobilised alone in alginate beads, respectively. In a study of the in vitro dissolution of U 3 O 8 by baboon AM in alginate beads, Poncy et al. (46) obtained a dissolution half-time of 1280 d for the phagocytised particles and a dissolution half-time of 650 d for particles immobilised alone in alginate beads. The increase in dissolution time is the result of the precipitation of the solubilised uranium oxide inside the lysosome of the AM as insoluble uranyl phosphate (47 -49) . At any point in time R(t), the retention or lung burden in the absence of particle transport, can be expressed as the sum of two exponential functions
where f r is the fraction of the deposited material that dissolves at rate l r -the rapid dissolution rate, while fraction (1 2 f r ) dissolves at rate l s -the slow dissolution rate, as described in the human respiratory tract model (HRTM) (50) . In a study on the dissolution of U 3 O 8 and UO 3 instilled in SpragueDawley rats, the values for f r , l r and l s obtained by Ansoborlo et al. (8) for in vivo dissolution, are as follows: 
A search of the scientific literature for similar studies for U 4 O 9 was unsuccessful. As suggested in the Capstone Report (2) , a DU particle has 3% U 4 O 9 , and since this is a relatively small contribution, it will be ignored. The Capstone report also indicates that any measurement of the amount of U 3 O 8 in a DU sample also includes an unspecified small amount of UO 3 , this ambiguity will also be ignored. Thus, the DU particle will be taken to be 95% U 3 O 8 and 5% UO 3 . As mentioned the DU samples analysed contained small amounts of UO 3 2H 2 O, which has an in vitro solubility that is less than that of UO 3 (45) . In this study, the in vivo dissolution rates of the UO 3 2H 2 O will be taken to be those of UO 3 .
Estimating the fraction that will translocate to the blood Expressions (2) and (3) were determined by measuring the amount of uranium oxides left in the lungs, which means solid plus dissolved uranium oxides. In the HRTM, l r and l s are the rapid and slow extracellular dissolution rates.
However, due to the highly efficient phagocytic function of the AM, the dissolution of the particles takes place mostly inside the AMs. Thus, l r and l s should be redefined to represent the rapid and slow rates of reduction of the amount of uranium oxides. If D(t) is the amount of uranium oxides that cross the plasma membrane and P(t) is the amount of uranyl phosphates, then one must have that dR/dt ! dD/dt þ dP/dt, which includes the case where there is accumulation of dissolved material inside the AM.
In the absence of any experimental data to the contrary, it will be assumed that, for first-order approximation, (i) the rate at which the dissolved uranium enters the blood is a dR/dt, for a constant and ,1 and (ii) the rate at which the uranyl phosphates precipitate is (1 2 a) dR/dt, which means that there is no accumulation of dissolved uranium oxides inside the macrophage-the plasma membrane is being idealised to have perfect permeability.
Expression (2) (46) . In this case one gets a ¼ 0.373. Differences in the physical and chemical characteristics of the test particles would result, at most, in a different estimated value for a, but will not preclude the harmonisation, whether the same species are involved or not. Thus, less than 60.88% of the DU particle will dissolve and precipitate as insoluble uranyl phosphates. The presence of such a process limits the amount of uranium that will diffuse across the cellular membrane (47) .
Depleted uranium oxides in the lungs and lymphatic nodes
In this study it is assumed that the duration of the inhalational exposure is negligible in comparison with the timescales of the other biological processes involved. Because of this, the inhalational exposure will be considered as being equivalent to an instillation.
Expressions (2) and (3) are applicable to the case when the uranium oxides are instilled. The mechanical transport of particles by the AM alters expressions (2) and (3). Let A 0 be the retention at time t ¼ 0 or time-zero lung burden. In order to simplify the calculations, it will be assumed that DU is 100% 238 U. 
where L(t) and N(t) are the amounts of DU oxides in the lungs and lymph nodes, respectively. Intracellular dissolution rates are independent of the macrophage's location.
Depleted uranyl phosphates in the lungs and lymph nodes
Let P l (t) and P n (t) be the amounts of dissolved uranium oxides (depleted) precipitated as insoluble uranyl phosphates, present in the lungs and lymph 
From Equation (8) one sees that uranium (depleted) in the amount of 8.6% of A 0 in weight, will eventually be permanently stored in the lymph nodes as insoluble uranyl phosphates.
Wrenn's pharmacokinetic model
In a pharmacokinetic model proposed by Wrenn et al. 
Thus, the rates of translocation from the blood into the associated compartment are,
Rate of excretion in the urine: estimating A 0
Let B(t) be the amount of dissolved DU in the blood. Let O skel (t) and O other (t) denote the amount of DU retained in the skeleton and 'other' target organ, respectively. Let T F (t), T S (t) and U(t) be the amounts of uranium in the fast and slow kinetic pools, and the rate at which uranium enters the urinary bladder, respectively. Uranium oxides that dissolve in the lymph nodes will enter the bloodstream in about 24 h after leaving the lymph node (52) . 
Let DU (t urine ) be the amount of DU measured in a 24-h urine sample collected between t ¼ t urine and t ¼ t urine þ 1, then
UðtÞ dt ð16Þ
Measurements of DU in 24-h urine samples from veterans of the Persian Gulf War I are included in Horan et al. (5) and Duraković et al. (6) . The 24-h urine samples were taken about 8-9 y after the end of the war. In one case the amount of DU reported is 6 26 mg of DU and that at 27.4 y (10000 d) the DU content of the urine sample will be 4.55 Â 10 27 mg.
Other considerations
As with all biological membranes, the plasma membrane is selectively permeable and has, in all cases, a less than perfect permeability. Thus, there will be accumulation of dissolved material inside the AM, which (i) will reduce the rate at which the dissolved oxides leak out of the AM and (ii) implies that the estimated amount of precipitated uranyl phosphates is the maximum possible.
In their study on the metabolism of ceramic and non-ceramic forms of UO 2 after deposition in the lungs of rats, Stradling et al. (53) report that the ceramic form dissolves in lung fluid at about half the rate of the non-ceramic form. A search of the scientific literature for similar studies for U 3 O 8 and UO 3 was unsuccessful. The cited studies on the intracellular dissolution of U 3 O 8 and UO 3 were carried out using the non-ceramic forms of these oxides. It is possible that the ceramic forms of U 3 O 8 and UO 3 also have lower intracellular and extracellular dissolution rates than the non-ceramic forms; this however, has been ignored. It is assumed that once the DU is dissolved, the fraction that precipitates is the same for both ceramic and non-ceramic forms.
CONCLUSION
Because of the AM's efficiency in sequestering foreign particles, the intracellular dissolution dominates the dissolution process of the DU particles. The presence of the precipitation of dissolved uranium oxides as uranyl phosphates limits the amount of DU that will be uptaken by the organism, but it also ensures the permanent sequestration in the lymph nodes of a fraction of the precipitated insoluble uranyl phosphates. The estimated amount of uranium absorbed is not insignificant since the estimates of the total body burden of uranium in the human body vary from 2 to 90 mg (34, 54) . The amount permanently sequestered in the lymph nodes is %10% of the timezero lung burden. The amount of uranium in the skeleton will monotonically increase for 747 days to a value of %0.11 mg and then will slowly decrease. Thus, 17 y after contamination, %5 Â 10 23 mg of DU will remain in the skeleton, while after 27.4 y the amount is %4 Â 10 24 mg. It takes a long time for the uptaken DU to vacate the body.
